HIKMA PHARMACEUTIC.LS-,10/ GB00B0LCW083 /
2024-08-28 10:59:26 PM | Chg. -0.200 | Volume | Bid10:59:26 PM | Ask10:59:26 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
23.600EUR | -0.84% | - Turnover: - |
23.600Bid Size: - | 23.800Ask Size: - | 5.22 bill.EUR | - | - |
Assets
|
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 421.4000 | 419.9000 | 443 | 514 | 507 | ||||||
Intangible Assets | 408.8000 | 433 | 447 | 602 | 607 | ||||||
Long-Term Investments | 49.5000 | 49.4000 | 56 | 55 | 53 | ||||||
Fixed Assets | 915.8000 | 948.1000 | 1,032 | 1,238 | 1,237 | ||||||
Inventories | 239.3000 | 272.3000 | 276 | 273 | 251 | ||||||
Accounts Receivable | 315.9000 | 328.1000 | 439 | 439 | 488 | ||||||
Cash and Cash Equivalents | 94.7000 | 176.5000 | 168 | 280 | 553 | ||||||
Current Assets | 659.9000 | 782 | 897 | 1,013 | 1,360 | ||||||
Total Assets | 1,575.6000 | 1,730.1000 | 1,929 | 2,251 | 2,597 |
Liabilities
|
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 169.2000 | 194.8000 | 241 | 248 | 276 | ||||||
Long-term debt | 344.9000 | 372.5000 | 263 | 145 | 590 | ||||||
Liabilities to Banks | 497.8000 | 565.4000 | 422 | 538 | 705 | ||||||
Provisions | 32.5000 | 33.6000 | 46 | 50 | 49 | ||||||
Liabilities | 777 | 882.3000 | 895 | 1,035 | 1,245 | ||||||
Share Capital | 34.9000 | 35.1000 | 35.2000 | 35.2000 | 35.2000 | ||||||
Total Equity | 776.6000 | 832.7000 | 1,017 | 1,197 | 1,337 | ||||||
Minority Interests | 22.1000 | 15.2000 | 17 | 19 | 15 | ||||||
Total liabilities equity | 1,575.6000 | 1,730.1000 | 1,929 | 2,251 | 2,597 |
Income Statement
|
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 918 | 1,108.7000 | 1,365 | 1,489 | 1,440 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 118.7000 | 166.8000 | 352 | 402 | 381 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 93.9000 | 132 | 298 | 362 | 318 | ||||||
Income Taxes | -10.4000 | -24.8000 | -82 | -80 | -64 | ||||||
Minority Interests Profit | -3.4000 | -6.9000 | -4 | -4 | -2 | ||||||
Net Income | 80.1000 | 100.3000 | 212 | 278 | 252 |
Per Share
Cash Flow
|
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 126.4000 | 182.2000 | 337 | 425 | 366 | ||||||
Cash Flow from Investing Activities | -343.5000 | -101 | -115 | -342 | -162 | ||||||
Cash Flow from Financing | 249.7000 | 6 | -229 | 30 | 77 | ||||||
Decrease / Increase in Cash | 32.6000 | 87.1000 | -7 | 113 | 281 | ||||||
Employees | 6,165 | 6,649 | 7,067 | 7,139 | 7,189 |